← Back to Search

Lumbar vs Extraventricular Drains for Subarachnoid Hemorrhage

N/A

Recruiting

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients received at the UCSD Medical Center with grade II, III, IV subarachnoid hemorrhage or patients with aneurysmal SAH with radiographic evidence.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-14 days

Awards & highlights

Study Summary

This trial would compare the outcomes of two methods of treatment for vasospasm after rupture of intracranial aneurysms.

Who is the study for?

This trial is for adults at UCSD Medical Center with a grade II, III, or IV subarachnoid hemorrhage (SAH) from a ruptured aneurysm and visible blood in brain scans. It excludes anyone under 18.Check my eligibility

What is being tested?

The study compares two methods to drain blood after SAH: extraventricular drain (EVD) and lumbar drain (LD). Patients will be randomly assigned to one of these treatments to see which better prevents vasospasm, reduces ICU stay, and lessens the need for permanent shunts.See study design

What are the potential side effects?

Potential side effects may include discomfort at the drainage site, infection risk around the brain or spine where drains are placed, possible bleeding during insertion or removal of drains, and headaches.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a grade II-IV subarachnoid hemorrhage or aneurysmal SAH confirmed by imaging.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-14 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-14 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vasopasm

Trial Design

2Treatment groups

Active Control

Group I: EVDActive Control1 Intervention

Patients will have extraventricular drain to manage CSF subarachnoid blood.

Group II: LDActive Control1 Intervention

Patients will have lumbar drain to manage CSF subarachnoid blood.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor

1,121 Previous Clinical Trials

1,521,325 Total Patients Enrolled

Media Library

Extraventricular Drain Clinical Trial Eligibility Overview. Trial Name: NCT03065231 — N/A

Subarachnoid Hemorrhage Research Study Groups: EVD, LD

Subarachnoid Hemorrhage Clinical Trial 2023: Extraventricular Drain Highlights & Side Effects. Trial Name: NCT03065231 — N/A

Extraventricular Drain 2023 Treatment Timeline for Medical Study. Trial Name: NCT03065231 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which demographic is eligible to partake in this research?

"The medical trial has set the qualifications for participants to have experienced subarachnoid hemorrhage and be aged between 18-110. Around 100 individuals will be chosen as candidates for this clinical research."

Answered by AI

What is the aggregate count of participants registering for this experiment?

"Affirmative. The research posted on clinicaltrials.gov verifies that this investigation is presently searching for participants, which was originally listed on the 1st of January 2017 and updated as recently as August 2nd 2021. A total of 100 individuals need to be recruited from one location."

Answered by AI

Can individuals join this research endeavor currently?

"Affirmative. The information hosted on clinicaltrials.gov shows that this medical trial, which was initiated on January 1st 2017, is presently enrolling participants. A total of 100 individuals need to be sourced from one particular research centre."

Answered by AI